Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Enveric Biosciences Says On March 5, The United States Patent And Trademark Office Issued Patent Titled "Multi-substituent Psilocybin Derivatives" And Is Further Expected To Issue, On March 19, Patent Titled "Nitrilated Psilocybin Derivatives"

Author: Benzinga Newsdesk | March 12, 2024 07:10am

Posted In: ENVB